Zopiclone Zopisign

Product Description
Zopiclone (brand name Zopisign) is a prescription medication used to treat short-term insomnia and sleep disturbances. It helps you fall asleep faster, stay asleep longer, and improves overall sleep quality. Zopisign belongs to a class of medicines known as non-benzodiazepine hypnotics, which work by calming the brain to promote restful sleep.

Advantages

• Promotes quick sleep onset

• Improves sleep duration and quality

• Reduces night-time awakenings

• Helps you wake up feeling refreshed

• Provides effective short-term relief from insomnia

Disadvantages

• May cause dizziness, dry mouth, or daytime drowsiness

• Can lead to dependency if used long-term

• Not suitable for people with liver or kidney problems without medical advice

• Avoid during pregnancy or breastfeeding

• Should not be mixed with alcohol or other sedatives

Usage

• Used for short-term treatment of insomnia

• Helps with difficulty in falling or staying asleep

• Works best when taken just before bedtime

When to Use

• If you experience trouble sleeping or frequent awakenings

• When lack of sleep affects your daily routine

• Only under a doctor’s prescription

Precautions

• Take under medical supervision only

• Avoid alcohol and sedatives

• Do not drive or operate machinery after taking

• Not suitable for children under 18 years

• Avoid if you have a history of substance abuse or mental health issues

How to Use

• Take the prescribed dose orally with water before bedtime

• Ensure at least 7–8 hours of uninterrupted sleep

• Do not exceed the prescribed dose

• Swallow the tablet whole—do not crush or chew

Other Details

• Generic Name: Zopiclone

• Brand: Zopisign

• Form: Oral Tablet

• Strength: Available in 7.5 mg and 10 mg (as prescribed)

• Storage: Store in a cool, dry place away from moisture and sunlight

• Shelf Life: Check the package for expiry date

Disclaimer:
This content is for educational purposes only. Always consult your healthcare provider before using Zopiclone – Zopisign.